Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04713735 · ClinicalTrials.gov registry record · NA

Impact of Lactoferrin, a Dietary Supplement, vs. Placebo on Respiratory Tract Infections

A NA study, sponsored by Mead Johnson Nutrition.

Completed
Registry status
NA
Development phase
76
Enrollment target

NCT04713735: Completed NA study, sponsored by Mead Johnson Nutrition.

NCT04713735 is a NA study that has completed, run by Mead Johnson Nutrition. The registered enrollment target is 76 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04713735, a NA study, has completed, sponsored by Mead Johnson Nutrition.

COMPLETED
Registry status
NA
Development phase
76 participants
Enrollment target

Study Summary

This is a randomized, double-blind, placebo-controlled study to evaluate the impact of bovine Lactoferrin (bLf) on respiratory tract infections (RTIs) in an elderly population in the United States.

Interventions

  • DIETARY_SUPPLEMENT bovine lactoferrin supplement
  • DIETARY_SUPPLEMENT Control: Placebo

Trial Details

FieldValue
Enrollment Target 76 participants
Start Date 2021-02-08
Est. Completion 2023-04-28
Phase NA
Mead Johnson Nutrition

34 total trials

What the finished NCT04713735 record still lists

NCT04713735 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 76 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 2 interventions - of which bovine lactoferrin supplement is the first listed.

NCT04713735 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04713735 about?

NCT04713735 is a clinical study titled "Impact of Lactoferrin, a Dietary Supplement, vs. Placebo on Respiratory Tract Infections". This is a randomized, double-blind, placebo-controlled study to evaluate the impact of bovine Lactoferrin (bLf) on respiratory tract infections (RTIs) in an elderly population in the United States.

What is the current status of trial NCT04713735?

This trial is currently completed. It is a NA study. The enrollment target is 76 participants. The study started on 2021-02-08. Estimated completion is 2023-04-28.

What interventions are being tested in trial NCT04713735?

The interventions under investigation include: bovine lactoferrin supplement (DIETARY_SUPPLEMENT), Control: Placebo (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT04713735?

This trial is sponsored by Mead Johnson Nutrition, which has 34 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04713735's enrollment target sits among peer trials

76 1062nd of 2000 higher than 932 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02615184 · 76 participants · Phase 2

    A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old

  • NCT02821741 · 76 participants · NA

    Effects of External Ear Stimulation on Pain Perception and Mood

  • NCT03019757 · 76 participants

    Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease

  • NCT03353584 · 76 participants · NA

    Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04713735, the US trial registry maintained by the National Library of Medicine. NCT04713735 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.